Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05816239 · ClinicalTrials.gov registry record
LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study
A clinical trial of Lung Perfusion, sponsored by Sameer Avasarala.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT05816239: Completed study of Lung Perfusion, sponsored by Sameer Avasarala.
NCT05816239 is a study of Lung Perfusion that has completed, run by Sameer Avasarala. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05816239, a study of Lung Perfusion, has completed, sponsored by Sameer Avasarala.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Cleveland Medical Center. All of the participants from this study will undergo their valve procedure at University Hospitals Cleveland Medical Center.
Conditions Studied
Interventions
- PROCEDURE Dual Energy CT
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2025-05-24 |
What the finished NCT05816239 record still lists
NCT05816239 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 1 condition, with Lung Perfusion appearing as the primary indexed condition, and to 1 intervention - of which Dual Energy CT is the first listed.
NCT05816239 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05816239 about?
NCT05816239 is a clinical study titled "LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study". The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Clev...
What is the current status of trial NCT05816239?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2023-02-24. Estimated completion is 2025-05-24.
What conditions does trial NCT05816239 study?
This clinical trial studies the following conditions: Lung Perfusion.
What interventions are being tested in trial NCT05816239?
The interventions under investigation include: Dual Energy CT (PROCEDURE).
Who is sponsoring clinical trial NCT05816239?
This trial is sponsored by Sameer Avasarala, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05816239 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI